RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort

J. M. O’Sullivan; J. Taylor; A. Gerds; S. Buckley; C. N. Harrison; S. Oh; A. F. List; K. Howard; H. Dreau; A. Hamblin; A. J. Mead

doi:10.1038/s41375-023-02027-3

RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort

J. M. O’Sullivan, J. Taylor, A. Gerds, S. Buckley, C. N. Harrison, S. Oh, A. F. List, K. Howard, H. Dreau, A. Hamblin, A. J. Mead

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	2497-2501
Number of pages	5
Journal	Leukemia
Volume	37
Issue number	12
DOIs	https://doi.org/10.1038/s41375-023-02027-3
State	Published - Dec 2023

Access to Document

10.1038/s41375-023-02027-3

Cite this

@article{a82d1b17771649e39f6bab50939c3a9b,

title = "RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort",

author = "O{\textquoteright}Sullivan, {J. M.} and J. Taylor and A. Gerds and S. Buckley and Harrison, {C. N.} and S. Oh and List, {A. F.} and K. Howard and H. Dreau and A. Hamblin and Mead, {A. J.}",

year = "2023",

month = dec,

doi = "10.1038/s41375-023-02027-3",

language = "English",

volume = "37",

pages = "2497--2501",

journal = "Leukemia",

issn = "0887-6924",

number = "12",

}

TY - JOUR

T1 - RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis

T2 - molecular analysis of the PAC203 cohort

AU - O’Sullivan, J. M.

AU - Taylor, J.

AU - Gerds, A.

AU - Buckley, S.

AU - Harrison, C. N.

AU - Oh, S.

AU - List, A. F.

AU - Howard, K.

AU - Dreau, H.

AU - Hamblin, A.

AU - Mead, A. J.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85174510886&partnerID=8YFLogxK

U2 - 10.1038/s41375-023-02027-3

DO - 10.1038/s41375-023-02027-3

M3 - Article

C2 - 37864122

AN - SCOPUS:85174510886

SN - 0887-6924

VL - 37

SP - 2497

EP - 2501

JO - Leukemia

JF - Leukemia

IS - 12

ER -

RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort

Access to Document

Other files and links

Cite this